653 related articles for article (PubMed ID: 33752701)
1. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
Clayton K; Delpech JC; Herron S; Iwahara N; Ericsson M; Saito T; Saido TC; Ikezu S; Ikezu T
Mol Neurodegener; 2021 Mar; 16(1):18. PubMed ID: 33752701
[TBL] [Abstract][Full Text] [Related]
2. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
[TBL] [Abstract][Full Text] [Related]
3. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
[TBL] [Abstract][Full Text] [Related]
4. Increase in Tau Pathology in P290S
Huang M; Macdonald J; Lavenir I; Chen R; Craxton M; Slavik-Smith E; Davies SW; Goedert M
eNeuro; 2022; 9(6):. PubMed ID: 36635241
[TBL] [Abstract][Full Text] [Related]
5. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of Neurodegenerative Microglia Signature in Brain-Derived Extracellular Vesicles Isolated from Alzheimer's Disease Mouse Models.
Muraoka S; Jedrychowski MP; Iwahara N; Abdullah M; Onos KD; Keezer KJ; Hu J; Ikezu S; Howell GR; Gygi SP; Ikezu T
J Proteome Res; 2021 Mar; 20(3):1733-1743. PubMed ID: 33534581
[TBL] [Abstract][Full Text] [Related]
8. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
[TBL] [Abstract][Full Text] [Related]
9. Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App
Biechele G; Wind K; Blume T; Sacher C; Beyer L; Eckenweber F; Franzmeier N; Ewers M; Zott B; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Tahirovic S; Willem M; Bartenstein P; Cumming P; Rominger A; Herms J; Brendel M
Neuroimage; 2021 Apr; 230():117707. PubMed ID: 33385560
[TBL] [Abstract][Full Text] [Related]
10. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
11. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
[TBL] [Abstract][Full Text] [Related]
12. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
13. β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP
Jiang L; Roberts R; Wong M; Zhang L; Webber CJ; Libera J; Wang Z; Kilci A; Jenkins M; Ortiz AR; Dorrian L; Sun J; Sun G; Rashad S; Kornbrek C; Daley SA; Dedon PC; Nguyen B; Xia W; Saito T; Saido TC; Wolozin B
Front Neurosci; 2024; 18():1372297. PubMed ID: 38572146
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.
Davis SA; Gan KA; Dowell JA; Cairns NJ; Gitcho MA
Neurobiol Dis; 2017 Jul; 103():154-162. PubMed ID: 28416393
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
17. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
18. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis.
Sheng JG; Price DL; Koliatsos VE
J Neurosci; 2002 Nov; 22(22):9794-9. PubMed ID: 12427835
[TBL] [Abstract][Full Text] [Related]
19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
20. Humanization of the entire murine
Saito T; Mihira N; Matsuba Y; Sasaguri H; Hashimoto S; Narasimhan S; Zhang B; Murayama S; Higuchi M; Lee VMY; Trojanowski JQ; Saido TC
J Biol Chem; 2019 Aug; 294(34):12754-12765. PubMed ID: 31273083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
